Loading...

Yafi, Faysal

TitleAssistant Health Sciences Professor
InstitutionUniversity of California, Irvine
DepartmentUrology
Address1001 Health Sciences Road
CA 92697-3950
Phone(714) 456-5378
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yafi F, Alzweri L, McCaslin IR, Libby RP, Sangkum P, Sikka SC, Hellstrom WJG. Grower or shower? Predictors of change in penile length from the flaccid to erect state. Int J Impot Res. 2018 Aug 01. PMID: 30068977.
      View in: PubMed
    2. Yafi F, Diao L, DeLay KJ, DeYoung L, Talib R, Alzweri L, Brock G, Hellstrom WJG, Hatzichristodoulou G. Multi-institutional prospective analysis of intralesional injection of Collagenase Clostridium Histolyticum, tunical plication and partial plaque excision and grafting for the management of Peyronie's disease. Urology. 2018 Jul 27. PMID: 30059716.
      View in: PubMed
    3. Yafi F, Tallman CT, Seard ML, Jordan ML. Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80-150?cc). Int J Impot Res. 2018 Jul 25. PMID: 30046163.
      View in: PubMed
    4. Yafi F, Andrianne R, Alzweri L, Brady J, Butcher M, Chevalier D, DeLay KJ, Faix A, Hatzichristodoulou G, Hellstrom WJG, Jenkins L, Kohler TS, Osmonov D, Park SH, Schwabb MD, Valenzuela R, van Renterghem K, Wilson SK. Andrianne Mini-Jupette Graft at the Time of Inflatable Penile Prosthesis Placement for the Management of Post-Prostatectomy Climacturia and Minimal Urinary Incontinence. J Sex Med. 2018 May; 15(5):789-796. PMID: 29523479.
      View in: PubMed
    5. Cwikla DJ, Yafi F. Intralesional collagenase Clostridium histolyticum in the management of Peyronie's disease: current best practice. Ther Adv Urol. 2018 Apr; 10(4):139-153. PMID: 29560030.
      View in: PubMed
    6. Yafi F. Editorial Comment on: An Innovative Technique of Transurethral Seminal Vesiculoscopy with Ultrasonic Lithotripter for Severe, Persistent Hematospermia by Zhang et al. J Endourol. 2017 Dec; 31(12):1283. PMID: 29048203.
      View in: PubMed
    7. DeLay KJ, Haney NM, Chiang J, Stewart C, Yafi F, Angermeier K, Wood H, Boone T, Kavanagh AG, Gretzer M, Boyd S, Loh-Doyle JC, Hellstrom WJG. Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional, Retrospective Analysis. Urology. 2018 Mar; 113:160-165. PMID: 29223493.
      View in: PubMed
    8. Yafi F, Sharlip ID, Becher EF. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction. Sex Med Rev. 2018 Apr; 6(2):242-252. PMID: 28923561.
      View in: PubMed
    9. Nguyen HMT, DeLay KJ, Diao L, Haney NM, Anaissie J, Yafi F, Sikka SC, Hellstrom WJG. Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie's disease. Transl Androl Urol. 2017 Oct; 6(5):888-893. PMID: 29184788.
      View in: PubMed
    10. Diao L, Anaissie J, Nguyen HMT, Yafi F, Haney NM, DeLay KJ, Peak TC, Sikka SC, Hellstrom WJG. Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie's disease. Transl Androl Urol. 2017 Oct; 6(5):894-898. PMID: 29184789.
      View in: PubMed
    11. DeLay K, Diao L, Nguyen HMT, Zurawin J, Libby R, Yafi F, Hellstrom WJG. Successful Treatment of Residual Curvature in Peyronie Disease in Men Previously Treated With Intralesional Collagenase Clostridium Histolyticum. Urology. 2017 Dec; 110:110-113. PMID: 28886994.
      View in: PubMed
    12. Nguyen HMT, Anaissie J, DeLay KJ, Yafi F, Sikka SC, Hellstrom WJG. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease. J Sex Med. 2017 Oct; 14(10):1220-1225. PMID: 28874331.
      View in: PubMed
    13. La J, Roberts NH, Yafi F. Diet and Men's Sexual Health. Sex Med Rev. 2018 Jan; 6(1):54-68. PMID: 28778698.
      View in: PubMed
    14. Wilson SK, Mora-Estaves C, Egydio P, Ralph D, Habous M, Love C, Shamsodini A, Valenzuela R, Yafi F. Glans Necrosis Following Penile Prosthesis Implantation: Prevention and Treatment Suggestions. Urology. 2017 Sep; 107:144-148. PMID: 28648967.
      View in: PubMed
    15. Serefoglu EC, Smith TM, Kaufman GJ, Liu G, Yafi F, Hellstrom WJG. Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease. Urology. 2017 Sep; 107:155-160. PMID: 28554517.
      View in: PubMed
    16. Yafi F, Haney NM, Anaissie J, DeLay KJ, Trost L, Khera M, Hellstrom WJG. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology. 2017 Aug; 106:87-95. PMID: 28479477.
      View in: PubMed
    17. Yafi F. Editorial Comment. Urology. 2017 Jul; 105:190-191. PMID: 28438403.
      View in: PubMed
    18. Kuhlmann PK, DeLay KJ, Anaissie J, Hellstrom WJ, Yafi F. Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives. Patient Prefer Adherence. 2017; 11:431-448. PMID: 28280315.
      View in: PubMed
    19. Hatzichristodoulou G, Osmonov D, Kübler H, Hellstrom WJG, Yafi F. Contemporary Review of Grafting Techniques for the Surgical Treatment of Peyronie's Disease. Sex Med Rev. 2017 Oct; 5(4):544-552. PMID: 28258933.
      View in: PubMed
    20. Anaissie J, Roberts NH, Wang P, Yafi F. Testosterone Replacement Therapy and Components of the Metabolic Syndrome. Sex Med Rev. 2017 Apr; 5(2):200-210. PMID: 28202344.
      View in: PubMed
    21. Anaissie J, Yafi F, Traore EJ, Sikka SC, Hellstrom WJ. Survey of patient and partner satisfaction following collagenase Clostridium histolyticum treatment for Peyronie's disease. Andrology. 2017 03; 5(2):274-277. PMID: 28187522.
      View in: PubMed
    22. Chiang J, Yafi F, Dorsey PJ, Hellstrom WJ. The dangers of sexual enhancement supplements and counterfeit drugs to "treat" erectile dysfunction. Transl Androl Urol. 2017 Feb; 6(1):12-19. PMID: 28217446.
      View in: PubMed
    23. Yafi F, DeLay KJ, Hellstrom WJG. Author Reply. Urology. 2017 Feb; 100:130. PMID: 27931977.
      View in: PubMed
    24. Anaissie J, Yafi F, DeLay KJ, Traore EJ, Sikka SC, Hellstrom WJG. Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients With Peyronie's Disease. Urology. 2017 Feb; 100:125-130. PMID: 27816605.
      View in: PubMed
    25. Anaissie J, Hellstrom WJ, Yafi F. Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease: A 'Real World' Clinical Perspective. Drugs. 2016 Oct; 76(16):1523-1528. PMID: 27770352.
      View in: PubMed
    26. Yafi F, DeLay KJ, Stewart C, Chiang J, Sangkum P, Hellstrom WJ. Device Survival after Primary Implantation of an Artificial Urinary Sphincter for Male Stress Urinary Incontinence. J Urol. 2017 Mar; 197(3 Pt 1):759-765. PMID: 27614334.
      View in: PubMed
    27. Yafi F, Hatzichristodoulou G, DeLay KJ, Hellstrom WJ. Review of Management Options for Patients With Atypical Peyronie's Disease. Sex Med Rev. 2017 Apr; 5(2):211-221. PMID: 27544298.
      View in: PubMed
    28. Zurawin JL, Stewart CA, Anaissie JE, Yafi F, Hellstrom WJ. Avanafil for the treatment of erectile dysfunction. Expert Rev Clin Pharmacol. 2016 Sep; 9(9):1163-70. PMID: 27416913.
      View in: PubMed
    29. Anaissie J, Yafi F, Hellstrom WJ. Surgery is not indicated for the treatment of premature ejaculation. Transl Androl Urol. 2016 Aug; 5(4):607-12. PMID: 27652232; PMCID: PMC5001994.
      View in: PubMed, PubMed Central
    30. Hellstrom WJ, Yafi F. Current state of affairs of Peyronie's disease. Transl Androl Urol. 2016 Jun; 5(3):278-9. PMID: 27298773; PMCID: PMC4893508.
      View in: PubMed, PubMed Central
    31. Anaissie J, Yafi F. A review of surgical strategies for penile prosthesis implantation in patients with Peyronie's disease. Transl Androl Urol. 2016 Jun; 5(3):342-50. PMID: 27298781; PMCID: PMC4893506.
      View in: PubMed, PubMed Central
    32. Gur S, Peak T, Yafi F, Kadowitz PJ, Sikka SC, Hellstrom WJ. Mirabegron causes relaxation of human and rat corpus cavernosum: could it be a potential therapy for erectile dysfunction? BJU Int. 2016 09; 118(3):464-74. PMID: 27124860.
      View in: PubMed
    33. Sangkum P, Yafi F, Kim H, Bouljihad M, Ranjan M, Datta A, Mandava SH, Sikka SC, Abdel-Mageed AB, Hellstrom WJ. Effect of adipose tissue-derived stem cell injection in a rat model of urethral fibrosis. Can Urol Assoc J. 2016 May-Jun; 10(5-6):E175-E180. PMID: 27790299.
      View in: PubMed
    34. Yafi F, Anaissie J, Zurawin J, Sikka SC, Hellstrom WJ. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease. J Sex Med. 2016 Apr; 13(4):684-9. PMID: 27045265.
      View in: PubMed
    35. Traore EJ, Wang W, Yafi F, Hellstrom WJ. Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence. Ther Adv Urol. 2016 Jun; 8(3):192-202. PMID: 27247629; PMCID: PMC4872191.
      View in: PubMed, PubMed Central
    36. Bell MD, Yafi F, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W. Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study. World J Urol. 2016 Oct; 34(10):1405-9. PMID: 26906030.
      View in: PubMed
    37. Yafi F, Hatzichristodoulou G, Wang J, Anaissie J, Sikka SC, Hellstrom WJ. Outcomes of Surgical Management of Men With Peyronie's Disease With Hourglass Deformity. Urology. 2016 05; 91:119-23. PMID: 26876465.
      View in: PubMed
    38. Yafi F, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, Maggi M, Nelson CJ, Parish S, Salonia A, Tan R, Mulhall JP, Hellstrom WJ. Erectile dysfunction. Nat Rev Dis Primers. 2016 02 04; 2:16003. PMID: 27188339.
      View in: PubMed
    39. Yafi F, Powers MK, Zurawin J, Hellstrom WJ. Contemporary Review of Artificial Urinary Sphincters for Male Stress Urinary Incontinence. Sex Med Rev. 2016 Apr; 4(2):157-166. PMID: 27872025.
      View in: PubMed
    40. Peak TC, Richman A, Gur S, Yafi F, Hellstrom WJ. The Role of PDE5 Inhibitors and the NO/cGMP Pathway in Cancer. Sex Med Rev. 2016 Jan; 4(1):74-84. PMID: 27872007.
      View in: PubMed
    41. Katz EG, Moustafa AA, Heidenberg D, Haney N, Peak T, Lasker GF, Knoedler M, Rittenberg D, Rezk BM, Abd Elmageed ZY, Yafi F, Sikka S, Abdel-Mageed AB, Hellstrom WJ. Pioglitazone Enhances Survival and Regeneration of Pelvic Ganglion Neurons After Cavernosal Nerve Injury. Urology. 2016 Mar; 89:76-82. PMID: 26772642.
      View in: PubMed
    42. Yafi F, Hatzichristodoulou G, Knoedler CJ, Trost LW, Sikka SC, Hellstrom WJ. Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie's Disease. J Sex Med. 2015 Dec; 12(12):2492-8. PMID: 26646187.
      View in: PubMed
    43. Jones SD, Dukovac T, Sangkum P, Yafi F, Hellstrom WJ. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male. Sex Med Rev. 2015 Apr; 3(2):101-112. PMID: 27784544.
      View in: PubMed
    44. Yafi F, April D, Powers MK, Sangkum P, Hellstrom WJ. Penile Priapism, Clitoral Priapism, and Persistent Genital Arousal Disorder: A Contemporary Review. Sex Med Rev. 2015 Jul; 3(3):145-159. PMID: 27784607.
      View in: PubMed
    45. Peak TC, Mitchell GC, Yafi F, Hellstrom WJ. Role of collagenase clostridium histolyticum in Peyronie's disease. Biologics. 2015; 9:107-16. PMID: 26491251; PMCID: PMC4598203.
      View in: PubMed, PubMed Central
    46. Anaissie J, Powers MK, Hellstrom WJ, Yafi F. Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease. Drugs Today (Barc). 2015 Aug; 51(8):457-68. PMID: 26380384.
      View in: PubMed
    47. Yafi F, Libby RP, McCaslin IR, Sangkum P, Sikka SC, Hellstrom WJ. Failure to attain stretched penile length after intracavernosal injection of a vasodilator agent is predictive of veno-occlusive dysfunction on penile duplex Doppler ultrasonography. Andrology. 2015 Sep; 3(5):919-23. PMID: 26235901.
      View in: PubMed
    48. Stewart CA, Yafi F, Knoedler M, Mandava SH, McCaslin IR, Sangkum P, Sikka S, Trost L, Hellstrom WJ. Intralesional Injection of Interferon-a2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location. J Urol. 2015 Dec; 194(6):1704-7. PMID: 26144333.
      View in: PubMed
    49. Sangkum P, Yafi F, Kim H, Bouljihad M, Ranjan M, Datta A, Mandava SH, Sikka SC, Abdel-Mageed AB, Moparty K, Hellstrom WJ. Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis. Urology. 2015 Sep; 86(3):647.e1-6. PMID: 26126692; PMCID: PMC4914046.
      View in: PubMed, PubMed Central
    50. Yafi F, Pinsky MR, Sangkum P, Hellstrom WJ. Therapeutic advances in the treatment of Peyronie's disease. Andrology. 2015 Jul; 3(4):650-60. PMID: 26097120.
      View in: PubMed
    51. Yafi F, Sangkum P, McCaslin IR, Hellstrom WJ. Strategies for penile prosthesis placement in Peyronie's disease and corporal fibrosis. Curr Urol Rep. 2015 Apr; 16(4):21. PMID: 25712763.
      View in: PubMed
    52. Yafi F, Pinsky MR, Stewart C, Sangkum P, Ates E, Trost LW, Sikka SC, Hellstrom WJ. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease. J Urol. 2015 Sep; 194(3):754-8. PMID: 25804087.
      View in: PubMed
    53. Sangkum P, Levy J, Yafi F, Hellstrom WJ. Erectile dysfunction in urethral stricture and pelvic fracture urethral injury patients: diagnosis, treatment, and outcomes. Andrology. 2015 May; 3(3):443-9. PMID: 25784590.
      View in: PubMed
    54. Peak TC, Yafi F, Sangkum P, Hellstrom WJ. Emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs. 2015 Jun; 20(2):263-75. PMID: 25740087.
      View in: PubMed
    55. Sangkum P, Yafi F, Hellstrom WJ. Commentary on "validation of robot-assisted vasectomy reversal". Asian J Androl. 2015 Mar-Apr; 17(2):332. PMID: 25578941; PMCID: PMC4650458.
      View in: PubMed, PubMed Central
    56. Sangkum P, Gokce A, Tan RB, Bouljihad M, Kim H, Mandava SH, Saleem SN, Lasker GF, Yafi F, Abd Elmageed ZY, Moparty K, Sikka SC, Abdel-Mageed AB, Hellstrom WJ. Transforming Growth Factor-ß1 Induced Urethral Fibrosis in a Rat Model. J Urol. 2015 Sep; 194(3):820-7. PMID: 25676431.
      View in: PubMed
    57. Alrabeeah K, Yafi F, Flageole C, Phillips S, Wachter A, Bissonnette F, Kadoch IJ, Zini A. Testicular sperm aspiration for nonazoospermic men: sperm retrieval and intracytoplasmic sperm injection outcomes. Urology. 2014 Dec; 84(6):1342-6. PMID: 25432825.
      View in: PubMed
    58. Yafi F, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015 Feb; 33(2):66.e25-31. PMID: 25037483.
      View in: PubMed
    59. Yafi F, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Saad F, Bell D, Drachenberg D, Kassouf W. Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer. World J Urol. 2014 Oct; 32(5):1295-301. PMID: 24213922.
      View in: PubMed
    60. Yafi F, Zini A. Percutaneous epididymal sperm aspiration for men with obstructive azoospermia: predictors of successful sperm retrieval. Urology. 2013 Aug; 82(2):341-4. PMID: 23768519.
      View in: PubMed
    61. Al-Qaoud TM, Yafi F, Aprikian AG. From podium to press: The 10-year publication rate of abstracts presented at the annual meetings of the Quebec Urological Association (QUA). Can Urol Assoc J. 2013 May-Jun; 7(5-6):E407-10. PMID: 23826052; PMCID: PMC3699087.
      View in: PubMed, PubMed Central
    62. Fahmy M, Mansure JJ, Brimo F, Yafi F, Segal R, Althunayan A, Hicks J, Meeker A, Netto G, Kassouf W. Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer. Hum Pathol. 2013 Sep; 44(9):1766-72. PMID: 23623586.
      View in: PubMed
    63. Yafi F, Tanguay S, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Lacombe L, Chin J, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Kassouf W. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome. Urol Oncol. 2014 Jan; 32(1):31.e17-24. PMID: 23428535.
      View in: PubMed
    64. Yafi F, Brimo F, Auger M, Aprikian A, Tanguay S, Kassouf W. Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. Urol Oncol. 2014 Jan; 32(1):27.e1-6. PMID: 23410943.
      View in: PubMed
    65. Yafi F, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. BJU Int. 2012 Nov; 110(9):1317-23. PMID: 22500588.
      View in: PubMed
    66. Yafi F, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int. 2012 Jul; 110(2 Pt 2):E7-13. PMID: 22177329.
      View in: PubMed
    67. Segal R, Yafi F, Brimo F, Tanguay S, Aprikian A, Kassouf W. Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy? BJU Int. 2012 Apr; 109(7):1026-30. PMID: 21883838.
      View in: PubMed
    68. Yafi F, Aprikian AG, Tanguay S, Kassouf W. Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care system. Can Urol Assoc J. 2011 Apr; 5(2):97-101. PMID: 21470533; PMCID: PMC3104421.
      View in: PubMed, PubMed Central
    69. Yafi F, North S, Kassouf W. First- and second-line therapy for metastatic urothelial carcinoma of the bladder. Curr Oncol. 2011 Jan; 18(1):e25-34. PMID: 21331269; PMCID: PMC3031362.
      View in: PubMed, PubMed Central
    70. Yafi F, Aprikian AG, Tanguay S, Kassouf W. Are men on 5a-reductase inhibitors appropriately referred to urology? A survey of primary care physicians. BJU Int. 2011 Oct; 108(8):1269-73. PMID: 21199285.
      View in: PubMed
    71. Yafi F, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Drachenberg D, Kassouf W. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int. 2011 Aug; 108(4):539-45. PMID: 21166753.
      View in: PubMed
    72. Moussa S, Yafi F, El-Hakim A, Fahmy N, Aprikian A, Tanguay S, Anidjar M, Kassouf W. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison. Urol Int. 2010; 84(1):50-5. PMID: 20173369.
      View in: PubMed
    73. Yafi F, Kassouf W. Management of patients with advanced bladder cancer following major response to systemic chemotherapy. Expert Rev Anticancer Ther. 2009 Dec; 9(12):1757-64. PMID: 19954287.
      View in: PubMed
    74. Yafi F, Cury FL, Kassouf W. Organ-sparing strategies in the management of invasive bladder cancer. Expert Rev Anticancer Ther. 2009 Dec; 9(12):1765-75. PMID: 19954288.
      View in: PubMed
    75. Yafi F, Kassouf W. Role of lymphadenectomy for invasive bladder cancer. Can Urol Assoc J. 2009 Dec; 3(6 Suppl 4):S206-10. PMID: 20019986; PMCID: PMC2792445.
      View in: PubMed, PubMed Central
    76. Yafi F, Kassouf W. Radical cystectomy is the treatment of choice for invasive bladder cancer. Can Urol Assoc J. 2009 Oct; 3(5):409-12. PMID: 19829738; PMCID: PMC2758501.
      View in: PubMed, PubMed Central
    77. Yafi F, Duclos M, Correa JA, Tanguay S, Aprikian AG, Cury F, Souhami L, Rajan R, Kassouf W. Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer. Urol Oncol. 2011 May-Jun; 29(3):309-13. PMID: 19595614.
      View in: PubMed
    78. Yafi F, Kassouf W. Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer? Expert Rev Anticancer Ther. 2009 Jun; 9(6):747-52. PMID: 19496711.
      View in: PubMed
    79. Yafi F, Steinberg JR, Kassouf W. Contemporary management of muscle-invasive bladder cancer. Int J Clin Oncol. 2008 Dec; 13(6):504-9. PMID: 19093177.
      View in: PubMed
    Faysal's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (156) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (4) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    ↑